The rAd carrying PTEN (Ad5-PTEN) is an effective anti-liver cancer drug; aptamer EpDT3 can specifically bind to epithelial cell adhesion molecule (EpCAM) and target EpCAM-positive cells. Here, EPCAM is linked to liver cancer.